Saudi Arabia Blood Glucose Device Market Size and Trends 2026-2034

Saudi Arabia Blood Glucose Device Market is expected to reach US$ 211.04 million by 2034 from US$ 113.64 million in 2025, with a CAGR of 7.12% from 2026 to 2034. Saudi Arabia’s blood glucose device market is advancing with growing diabetes management needs, higher awareness of regular glucose monitoring, broader homecare adoption, stronger retail access, and rising preference for convenient testing solutions.

Industry Overview of the Saudi Arabia Blood Glucose Device Market

The Saudi Arabia blood glucose device market is gaining momentum as the country continues to strengthen its response to the growing burden of diabetes and related metabolic disorders. Blood glucose devices are essential tools for monitoring glucose levels, supporting timely treatment decisions, and enabling better long-term disease management for patients living with diabetes. In Saudi Arabia, rising awareness about the importance of routine blood sugar monitoring is encouraging greater use of self-monitoring devices among patients, caregivers, and healthcare professionals. As diabetes care increasingly shifts toward early detection, preventive management, and patient engagement, blood glucose devices are becoming a more integral part of routine health management across hospitals, clinics, and homecare settings.

Technological development is playing a central role in shaping the blood glucose device market in Saudi Arabia. Manufacturers are focusing on more accurate, easy-to-use, and portable devices that can simplify testing for a broad range of users. Modern glucose meters are increasingly supported by digital interfaces, memory functions, and connectivity options that improve patient convenience and data tracking. The market is also being influenced by the growing use of test strips and accessories that support repeated monitoring in daily diabetes care. Demand is particularly strong among individuals managing Type 2 diabetes, where regular glucose tracking is critical to treatment adherence and lifestyle adjustments. As awareness of self-care continues to improve, demand for reliable glucose monitoring devices is expected to strengthen further.

The distribution environment is also expanding, with retail pharmacies and healthcare providers playing a vital role in product availability and patient education. Pharmacies remain an important channel because they offer easy access to blood glucose monitors, strips, and diabetes management supplies for both urban and semi-urban populations. At the same time, healthcare institutions continue to guide patients on appropriate device selection and testing frequency. Homecare adoption is rising as more patients prefer monitoring their glucose levels independently outside hospital environments. However, market development can still be influenced by affordability concerns, varying levels of patient awareness, and the need for consistent education on proper device use. Overall, the Saudi Arabia blood glucose device market is expected to remain on a positive growth path as diabetes management becomes increasingly patient-centered, accessible, and technology-enabled.

Recent Developments in Saudi Arabia Blood Glucose Device Market

• In 2024, Amplifai Health, a Saudi health-tech startup, will collaborate with King Abdullah University of Science and Technology to create an enhanced diabetes diagnosis system. This venture will use Amplifai Health's AI and Hyplex hyperspectral imaging technology to diagnose and manage diabetic foot problems in an upcoming clinical trial.

Core Growth Drivers of the Saudi Arabia Blood Glucose Device Market

Promoting Health Awareness and Government Initiatives

Another key element is Saudi citizens' increased health consciousness, which is aided by government programs targeted at improving public health. The Saudi government actively supports campaigns to raise awareness of the need of diabetes prevention, early diagnosis, and adequate care. These adverts usually emphasize the importance of blood glucose monitoring in maintaining adequate control of the condition and preventing consequences. For example, in 2024, the Saudi Ministry of Health collaborated with Ithnain to improve diabetes management by providing creative coaching to over 10,000 patients and aligning with Vision 2030 to expand healthcare solutions throughout the Kingdom. This effort aligns with Saudi Arabia's national health policy under Vision 2030 and demonstrates the country's rising emphasis on diabetes awareness and management.

Technological Developments in Monitoring Devices

Technological advancements have transformed the blood glucose monitoring device market, introducing improvements that provide more convenience, precision, and use. Patients can now better manage their condition outside of clinical settings because to the introduction of non-invasive technologies, continuous glucose monitors (CGMs), and smartphone-enabled glucose monitoring systems. For example, in 2024, Abbott worked with Medtronic to combine FreeStyle Libre CGM, which is available in Saudi Arabia, with Medtronic's AID and smart insulin pens, enhancing diabetes care for over 11 million individuals worldwide who require intense insulin therapy. These gadgets provide real-time data, allowing users to continuously track their blood glucose levels throughout the day. Such technological breakthroughs have boosted the need for modern, high-tech solutions among Saudi diabetic patients, who are increasingly looking for smarter and more effective ways to treat their condition.

Diabetes is becoming increasingly prevalent

The increasing prevalence of diabetes, particularly type 2 diabetes, is a major driver of the blood glucose monitoring devices market in Saudi Arabia. Saudi Arabia has one of the highest incidences of diabetes in the Middle East, with a large proportion of the population suffering from this chronic ailment. According to industry figures, over 20% of Saudi Arabia's population has diabetes. Sedentary lifestyles, bad diets, and an aging population all contribute to this growth. As a result, there is a growing demand for precise and user-friendly blood glucose monitoring and control devices, particularly for persons who have diabetes or are at risk of getting the condition.

Key Challenges in the Saudi Arabia Blood Glucose Device Market

Cost Sensitivity and Ongoing Supply Expenses

One of the primary challenges affecting the Saudi Arabia blood glucose device market is the recurring cost associated with long-term monitoring. While the glucose meter itself may be a one-time purchase, regular use of test strips, lancets, and related supplies can create ongoing financial pressure for patients who require frequent testing. This is particularly relevant for individuals managing chronic diabetes over many years. In some cases, affordability concerns may reduce testing frequency or encourage patients to delay replacement of essential supplies, which can affect monitoring consistency. Price sensitivity can also influence brand choice, potentially limiting access to higher-quality or more advanced devices. For suppliers and healthcare providers, ensuring a balance between affordability and reliability remains an important challenge. Expanding access to cost-effective products and strengthening patient support initiatives will be important to support wider and more sustainable market adoption.

Awareness Gaps and Improper Monitoring Practices

Although blood glucose devices are becoming more widely available in Saudi Arabia, inconsistent patient awareness and monitoring habits remain a challenge. Some individuals may not fully understand the importance of regular glucose testing, how often to monitor, or how to interpret results effectively in relation to diet, medication, and physical activity. Improper device handling, irregular testing schedules, and limited knowledge about test strip usage can reduce the effectiveness of self-monitoring. These issues may be more noticeable among newly diagnosed patients or those with limited access to structured diabetes education. Healthcare providers and pharmacies play an important role in addressing these gaps through patient counseling and practical guidance. Strengthening public awareness campaigns and diabetes education programs will be essential for improving correct device usage, supporting better treatment adherence, and ensuring the long-term success of blood glucose monitoring solutions in the Saudi market.

Dhahran Blood Glucose Device Market

Dhahran represents a developing market for blood glucose devices, supported by increasing awareness of chronic disease management and access to modern healthcare services. The city benefits from a relatively organized healthcare environment and a population that is becoming more conscious of preventive health practices. Blood glucose monitoring devices are gaining traction among patients who require regular diabetes management and prefer convenient self-testing tools that can be used at home. Pharmacies and healthcare providers in Dhahran are contributing to market development by improving product accessibility and patient understanding of glucose monitoring routines. Demand is also supported by growing interest in digital and portable health devices that align with evolving patient preferences for convenience and self-care. As awareness of regular blood sugar monitoring continues to improve and healthcare engagement strengthens, Dhahran is expected to remain an important regional market for blood glucose device adoption in Saudi Arabia.

Riyadh Blood Glucose Device Market

Riyadh is one of the most significant markets for blood glucose devices in Saudi Arabia due to its large urban population, advanced healthcare infrastructure, and strong access to diabetes care services. The city has a wide network of hospitals, clinics, diabetes specialists, and retail pharmacies that support the availability and use of blood glucose monitoring products. Patients in Riyadh are increasingly adopting self-monitoring devices as part of routine diabetes management, particularly in homecare settings where convenience and frequent testing are important. The city’s growing acceptance of health technology and digital patient engagement tools also supports demand for modern glucose monitoring solutions. Healthcare providers in Riyadh continue to promote regular blood sugar testing and patient education, which strengthens long-term device usage. With continued focus on preventive care and chronic disease management, Riyadh is expected to remain a major contributor to national market growth.

Khobar Blood Glucose Device Market

Khobar is emerging as an important market for blood glucose devices, supported by improving healthcare access, urban lifestyle changes, and increasing focus on diabetes management. The city’s healthcare providers and pharmacies are playing a key role in expanding awareness of blood sugar monitoring and the benefits of self-testing for chronic disease control. Patients in Khobar are gradually adopting blood glucose devices as part of daily diabetes management, especially those seeking convenient monitoring outside clinical environments. The market is also benefiting from growing availability of portable glucometers and essential supplies through retail channels. As consumer interest in home-based healthcare and preventive monitoring rises, blood glucose devices are becoming more relevant across a wider patient population. Continued improvements in healthcare services and stronger emphasis on self-care are expected to support the growth of the blood glucose device market in Khobar over the forecast period.

Jeddah Blood Glucose Device Market

Jeddah holds a prominent position in the Saudi Arabia blood glucose device market due to its large population base, established healthcare infrastructure, and growing demand for diabetes management solutions. The city has a strong network of hospitals, clinics, and pharmacies that facilitate access to glucose monitoring products and related patient support services. Demand for blood glucose devices in Jeddah is being supported by increasing awareness of routine diabetes monitoring and the convenience of self-testing at home. Patients are showing greater interest in portable and easy-to-use monitoring solutions that fit into daily life and support treatment adherence. Retail pharmacies remain an important channel for product availability and counseling. With rising attention on chronic disease prevention, digital health engagement, and homecare-based diabetes management, Jeddah is expected to remain a leading regional market for blood glucose device adoption in Saudi Arabia.

Test Strips Blood Glucose Device Market

Test strips represent a critical segment of the Saudi Arabia blood glucose device market because they are essential for routine glucose testing and directly influence the ongoing usability of glucose meters. Their demand is closely linked to the frequency of self-monitoring among diabetes patients, especially those who require regular tracking of blood sugar levels at home. Since test strips must be replaced frequently, they form a recurring component of diabetes management expenditure and contribute significantly to the day-to-day operation of blood glucose monitoring devices. Manufacturers and suppliers are focusing on improving strip reliability, compatibility, and ease of use to support accurate readings and user confidence. The availability of test strips through pharmacies and healthcare providers is especially important for maintaining uninterrupted diabetes monitoring. As self-testing becomes more common across Saudi Arabia, the test strips segment is expected to remain one of the most strategically important areas within the broader blood glucose device market.

Type 2 Diabetes Blood Glucose Device Market

The Type 2 diabetes segment is a major contributor to the Saudi Arabia blood glucose device market because individuals with this condition often require ongoing monitoring to manage blood sugar levels, medication routines, diet, and lifestyle adjustments. Blood glucose devices are widely used in this patient group to support daily decision-making and long-term treatment adherence. In many cases, regular self-monitoring helps users understand the effects of meals, exercise, and prescribed therapies on glucose control, making these devices an important part of disease management. Growing awareness of diabetes complications and the importance of preventive care is increasing the relevance of blood glucose monitoring among people living with Type 2 diabetes. Healthcare professionals also encourage regular testing for patients who need closer control of glycemic patterns. As diabetes management becomes more proactive and home-based, the Type 2 diabetes segment is expected to remain central to market demand in Saudi Arabia.

Retail Pharmacies Blood Glucose Device Market

Retail pharmacies play a vital role in the Saudi Arabia blood glucose device market by serving as one of the most accessible and trusted channels for glucose meters, test strips, lancets, and other diabetes care supplies. Pharmacies offer convenience for repeat purchases and often act as the first point of contact for patients seeking monitoring products or guidance on self-testing routines. Their role is especially important in supporting home-based diabetes management, where patients need reliable access to consumables and replacement supplies. Pharmacists can also contribute to patient awareness by explaining product use, encouraging monitoring adherence, and helping users choose suitable devices based on their needs. In urban centers and expanding residential areas, retail pharmacies strengthen market penetration by bringing blood glucose solutions closer to consumers. As self-care and chronic disease management continue to gain importance, the retail pharmacy segment is expected to remain a key distribution pillar in the Saudi market.

Basic Questions and Answers from the Saudi Arabia Blood Glucose Device Market

Q1. What is driving the growth of the Saudi Arabia blood glucose device market?

The market is growing due to rising diabetes prevalence, increasing demand for home-based glucose monitoring, improving awareness of routine testing, wider retail availability, and development of portable, user-friendly monitoring devices.

Q2. Why are blood glucose devices important for diabetes management?

Blood glucose devices help patients monitor sugar levels regularly, support medication and lifestyle decisions, improve treatment adherence, and reduce the risk of complications through more informed diabetes management.

Q3. How is home-based care influencing the Saudi blood glucose device market?

Home-based care is increasing demand for glucose monitoring devices because patients prefer convenient, independent testing options that reduce hospital visits and support regular diabetes management in everyday settings.

Q4. What role do test strips play in the blood glucose device market?

Test strips are essential for routine glucose testing because they work with blood glucose meters to provide readings, making them a recurring and strategically important part of diabetes monitoring.

Q5. What challenges affect blood glucose device adoption in Saudi Arabia?

Key challenges include recurring supply costs, affordability concerns, inconsistent patient awareness, irregular monitoring habits, improper device use, and the need for stronger diabetes education and guidance.

Q6. Why is the Type 2 diabetes segment important in this market?

Type 2 diabetes patients often require ongoing glucose monitoring for treatment management, lifestyle control, and complication prevention, making them a major source of demand for blood glucose devices.

Market Segmentation

Product

• Test Strips
• Lancets
• Blood Glucose Meters

Application

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

End User

• Hospital Pharmacies
• Retail Pharmacies
• Online Sales
• Diabetes Clinics & Centers

Cities

• Riyadh
• Jeddah
• Dammam
• Dhahran
• Jubail
• Khobar
• Tabuk
• Mecca
• Medina
• Rest of Cities

All the Key players have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Abbott Laboratories
• Medtronic
• Dexcom Inc.
• B. Braun Melsungen AG
• DarioHealth Corp
• Sanofi
• Bionime Corporation
• Novo Nordisk